MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of marketable...
$49,235K
Proceeds from exercises
of stock options
$14K
Net cash provided by
investing activities
$33,161K
Net cash provided by
financing activities
$14K
Canceled cashflow
$16,074K
Net (decrease)
increase in cash, cash...
-$407K
Canceled cashflow
$33,175K
Accounts payable
$6,762K
Share-based compensation
expense
$4,319K
Write-off of nonsalable
inventory
$414K
Depreciation and
amortization
$111K
Other assets
-$1K
Purchases of marketable
securities
$16,056K
Purchases of property and
equipment
$18K
Net cash used in
operating activities
-$33,582K
Canceled cashflow
$11,607K
Net loss
-$41,488K
Accrued liabilities
-$2,114K
Inventory
$889K
Prepaid expenses and
other current assets
$341K
Accretion of discounts and
amortization of premiums on...
$316K
Operating lease
liabilities, net
-$27K
Accounts receivable, net
$14K
Back
Back
Cash Flow
LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)
source: myfinsight.com